Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2004

View Archived Issues

S-21403 reported to reduce the effects of postprandial hyperglycemia in type 2 diabetes

Four series of PPAR modulators reported by Lilly

Novel CGRP antagonists for migraine therapy presented by Boehringer Ingelheim

Novel HIV integrase inhibitors in early development at BMS

Merck researchers develop new macrocyclic BACE inhibitors

New porphyrin derivatives and their use in cancer radiotherapy

New antitumor conjugates with improved half-life designed at Bracco

Cambridge Laboratories acquires U.K. rights to palonosetron

Sirna Therapeutics files IND to advance Sirna-027 into clinic

Mylan and King proceed with acquisition plans

Series B financing at MAP Pharmaceuticals to advance inhaled drug products

Vertex completes dosing in phase Ia study of VX-950 for HCV

Sunesis and Biogen Idec collaborate on small molecule oncology products

VaxGen cleared to begin clinical testing of smallpox vaccine LC16m8

Taisho and Arena identify potent MCH receptor antagonist ATC-0065

Novel small molecule VLA-4 antagonist for asthma reported by Uriach

Serono highlights second quarter developments

Crucell updates PER.C6 development

Schering-Plough reviews recent significant developments

First phase II Oxycyte protocol submitted

Good patient satisfaction achieved with Respimat SMI in the management of COPD

Clinical evidence suggests that TH-9507 improves functional performance of COPD patients

Treatment commences in West Nile study of Alferon N

Therapeutic benefits of the PPAR agonist muraglitazar in diabetes

Takara Bio and CAMS to codevelop cancer immunotherapies in China

ZymoGenetics and Serono establish broad alliance

Crucell signs PER.C6 license agreement with MorphoSys

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

MB-06322 demonstrates activity in preclinical models of diabetes

Activity of BLX-1002 assessed in vitro, in vivo

Novel, selective chemokine CXCR2 receptor antagonist SB-656933 inhibits neutrophil CD11b expression

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...